Recombinant SARS-CoV-2 Spike antibody

Catalog No. ABIN7795626

The Human Monoclonal anti-SARS-CoV-2 Spike antibody has been validated for ELISA. It is suitable to detect SARS-CoV-2 Spike in samples from SARS Coronavirus-2 (SARS-CoV-2).

Quick Overview for Recombinant SARS-CoV-2 Spike antibody (ABIN7795626)

Target: SARS-CoV-2 Spike (SARS-CoV-2 S)

Antibody Type: Recombinant Antibody

Reactivity: SARS Coronavirus-2 (SARS-CoV-2)

Host: Human

Clonality: Monoclonal

Conjugate: This SARS-CoV-2 Spike antibody is un-conjugated

Application: ELISA

Clone: CR3022-IgG1

Product Details anti-SARS-CoV-2 Spike Antibody

Purpose: Human anti-SARS-CoV S-RBD Recombinant Monoclonal Antibody [CR3022-IgG1]

Purification: Purified

Immunogen: SARS-CoV-Spike Protein

Isotype: IgG1

Application Details

Application Notes: ELISA,11000 - 150,000

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1000 μg/mL

Buffer: Phosphate Buffered Saline (PBS) containing 0.09 % Sodium Azide

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C

Storage Comment: 2 - 8 °C

Expiry Date: 12 months

Target Details for SARS-CoV-2 Spike

Target: SARS-CoV-2 Spike (SARS-CoV-2 S)

Alternative Name: SARS-CoV S-RBD

Target Type: Viral Protein

Background: The structural proteins of SARS-CoV-2 include the envelope protein (E), spike or surface glycoprotein (S), membrane protein (M) and the nucleocapsid protein (N). The spike glycoprotein is found on the outside of the virus particle and mediates attachment of the virus particle and entry into the host cell though an interaction with the virla receptor binding domain (RBD) and ACE2. The spike protein is an important target for vaccine development, antibody therapies and diagnostic antigen-based tests. (NCBI)

Gene ID: 43740568

UniProt: P0DTC2